Back to Search
Start Over
Compassionate Use of Letermovir in a 2-Year-Old Immunocompromised Child With Resistant Cytomegalovirus Disease.
- Source :
- Journal of the Pediatric Infectious Diseases Society; February 2020, Vol. 9 Issue: 1 p96-99, 4p
- Publication Year :
- 2020
-
Abstract
- Little information on the efficacy and pharmacokinetics of letermovir among immunocompromised children is currently available. We describe here the use of letermovir in a 2-year-old immunocompromised child with ganciclovir-resistant cytomegalovirus disease who required extracorporeal membrane oxygenation. Detailed information on therapeutic-drug-monitoring measures and dosage adjustments for letermovir is provided.
Details
- Language :
- English
- ISSN :
- 20487193 and 20487207
- Volume :
- 9
- Issue :
- 1
- Database :
- Supplemental Index
- Journal :
- Journal of the Pediatric Infectious Diseases Society
- Publication Type :
- Periodical
- Accession number :
- ejs52716317
- Full Text :
- https://doi.org/10.1093/jpids/piz033